Key Financial Figures - Anka India Limited (Standalone)
- Total Income from Operations: ₹105.00 lakh for quarter ended June 30, 2026
- Net Profit/(Loss) before tax and share of (Loss)/profit in associates & Joint ventures: (₹0.91) lakh
- Net Profit/(Loss) for the period after tax and exceptional items: ₹0.40 lakh
- Total Comprehensive (loss)/Income for the period: ₹0.40 lakh
- Paid up Equity Capital: ₹515.42 lakh (Face value of ₹10/- each)
- Earnings Per Share: Basic 0.001; Diluted 0.001
Key Financial Figures - Anka India Limited (Consolidated)
- Total Income from Operations: ₹1,809.43 lakh for year ended March 31, 2026
- Net Profit/(Loss) before tax and share of (Loss)/profit in associates & Joint ventures: (₹26.57) lakh
- Net Profit/(Loss) for the period after tax and exceptional items: (₹46.33) lakh
- Total Comprehensive (loss)/Income for the period: (₹46.05) lakh
- Paid up Equity Capital: ₹485.49 lakh
- Earnings Per Share: Basic (0.10); Diluted (0.10)
Important Dates and Actions
- Board Meeting Date: July 30, 2026 (approved financial results)
- Newspaper Publication Date: August 1, 2026
- Newspapers: Financial Express (English Daily) and Jansatta (Regional Language Daily)
- Financial Period: Quarter ended June 30, 2026
Material Disclosure
Qualified Audit Opinion: The Statutory Auditors of the Company have expressed a Qualified Opinion on the aforesaid financial results. The full format of the Financial Results, together with the Limited Review Report containing the Qualified Opinion, is available on the company website and BSE website.
Additional Information
- The company is operating in only one segment, hence segment reporting is not provided
- Figures wherever required are regrouped/rearranged
- Results prepared in accordance with Indian Accounting Standards (Ind AS)
- Full results available on BSE website (www.bseindia.com) and company website (www.ankaindia.com)
Other Companies' Results Included in Filing
The document also contains financial results extracts for:
1. SMS Pharmaceuticals Limited: Showing standalone total income of ₹20,870.93 lakh and net profit of ₹2,113.26 lakh for June 30, 2026 quarter
2. Clean Max Enviro Energy Solutions Limited: Consolidated net profit of ₹551.74 million on income of ₹8,741.02 million for June 2026 quarter
3. Concord Biotech Limited: Standalone net profit of ₹6,119.37 lakh on income of ₹26,051.71 lakh for June 2026 quarter